Learning Objectives:
1. Gain new insights into myelodysplastic syndromes (MDS) and sickle cell disease (SCD)
2. Delineate molecular mechanisms underlying epigenetic regulation of transcription
3. To understand the benefits of non-cytotoxic drugs for treatment of MDS and SCD
Session date:
02/14/2022 - 12:00pm to 1:00pm CST
Location:
Virtual
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Amittha Wickrema